Get notified when BF-B files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: BF-B BROWN FORMAN CORP 10-Q

Brown-Forman Q1 sales slip 1% to $1.18B; EPS rises 6% to $0.38 on lower costs

Filed September 2, 2026 · Period ending July 31, 2026 · Compared to 10-Q Aug 28, 2025 · ~1 min read

Key Changes

  • high

    Net sales fell 1% to $1.18B in Q1 FY27, driven by unfavorable price/mix and the end of the Korbel relationship, partially offset by higher volumes and favorable FX.

    MD&A: Net sales verify on EDGAR →
  • high

    Operating income declined 3% to $252M, as higher operating expenses more than offset gross margin expansion.

    MD&A: Operating income verify on EDGAR →
  • high

    Diluted EPS rose 6% to $0.38, helped by lower non-operating postretirement expense and share buybacks, despite the operating income decline.

    MD&A: Diluted EPS verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (IMMR 10-Q) is open in full — no account needed.

Partner

Trade BF-B commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 17, 2026 · How we verify